Fluoroscopy Equipment Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Fixed C-arms, Fluoroscopy Systems, Remote Controlled Systems, Patient-Side Controlled Systems, Others), By Application (Diagnostics {Cardiology, Gastroenterology, Urology & Nephrology, Others}, Surgical {Orthopedic & Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries, Others}), By End User (Hospitals & Clinics, Diagnostic Imaging Centers, Others), By Region & Competition, 2020-2030F

Market Overview

The Fluoroscopy Equipment market was valued at USD 6.28 Billion in 2024 and is expected to reach USD 7.72 Billion by 2030 with a CAGR of 3.45%. The Global Fluoroscopy Equipment Market is experiencing consistent growth, propelled by rising clinical demand, continuous technological advancements, and the global shift toward minimally invasive diagnostic and therapeutic procedures. As a real-time imaging modality, fluoroscopy is gaining traction across a broad range of medical specialties supporting everything from routine diagnostics to complex, image-guided interventions.

The market is set for sustained expansion, with high-value system adoption concentrated in developed regions, while emerging markets are expected to drive significant volume-based growth. Manufacturers that prioritize modular system design, intuitive user interfaces, and cost-effective performance will be best positioned to capitalize on the evolving needs of healthcare providers worldwide. The ability to deliver scalable, workflow-optimized solutions will be a key differentiator in this increasingly competitive global landscape.

Key Market Drivers

Growing Burden of Chronic Diseases

The growing burden of chronic diseases and the aging global population are two of the most influential drivers accelerating the growth of the Global Fluoroscopy Equipment Market. Chronic diseases are a leading cause of mortality worldwide, contributing to an estimated 41 million deaths each year representing a substantial share of the global health burden. These factors are increasing the clinical demand for real-time, image-guided diagnostics and procedures, positioning fluoroscopy as an essential tool in modern healthcare delivery. Chronic diseases such as cardiovascular disorders, orthopedic conditions, gastrointestinal diseases, and cancer are on a sharp rise worldwide, largely due to sedentary lifestyles, poor diet, and longer life expectancies. Cardiovascular diseases (CVDs) such as heart attacks and strokes remain the foremost cause of death worldwide, accounting for approximately 17.9 million fatalities each year and underscoring their critical impact on global health systems and policy priorities. Managing these conditions often requires frequent imaging for diagnosis, monitoring, and treatment planning. Fluoroscopy systems enable continuous, real-time X-ray imaging, which is especially critical in procedures like: Cardiac catheterizations for coronary artery disease, Spinal interventions for degenerative disc disorders, GI studies for esophageal, gastric, and bowel disorders Interventional oncology procedures for tumor ablation and biopsy guidance. As the prevalence of these diseases grows, hospitals and outpatient centers are performing higher volumes of fluoroscopy-guided interventions, significantly boosting market demand.

By 2050, approximately 80% of the global elderly population will reside in low- and middle-income countries, highlighting a major demographic shift. The rate of population aging is accelerating significantly compared to previous decades. Notably, in 2020, the number of individuals aged 60 and above surpassed the population of children under five. Between 2015 and 2050, the share of people over 60 is projected to almost double from 12% to 22% reflecting a profound transformation in the global age structure. This demographic is highly prone to conditions such as: Osteoporosis and related fractures, Arthritis and joint degeneration, Cardiovascular complications, Neurological disorders requiring spinal or cranial interventions. Elderly patients often require minimally invasive procedures to minimize surgical risk and recovery time. Fluoroscopy facilitates such procedures by offering precise, real-time guidance with minimal disruption to surrounding tissues, making it a preferred imaging modality for geriatric care.

As healthcare systems transition from reactive to preventive and long-term care models, regular monitoring and early intervention become critical especially for aging populations and chronic disease patients. Fluoroscopy plays an important role in this shift by enabling: Early detection of structural abnormalities, Guided placement of therapeutic devices (e.g., stents, catheters), Assessment of functional movement in musculoskeletal cases. This extended use of fluoroscopy across the patient care continuum from diagnosis to treatment and follow-up significantly broadens its application scope and justifies continued investment in new-generation systems. In developed regions such as North America and Western Europe, advanced fluoroscopy systems are being adopted to support high volumes of chronic disease-related procedures. Meanwhile, in emerging economies experiencing rapid population aging and urbanization, there is rising demand for diagnostic infrastructure to manage the expanding burden of chronic illnesses. Governments and private health providers in countries like China, India, and Brazil are increasingly equipping hospitals with hybrid and mobile fluoroscopy units to meet this demand further expanding the global market footprint.

Rising Demand for Minimally Invasive Procedures

The rising demand for minimally invasive procedures (MIS) is a powerful force propelling the growth of the Global Fluoroscopy Equipment Market. As healthcare systems worldwide shift toward less invasive surgical approaches to improve patient outcomes, reduce hospital stays, and lower overall treatment costs, fluoroscopy has emerged as a critical enabler of this transformation. Minimally invasive procedures require a high degree of precision due to limited visibility and small incisions. Fluoroscopy provides real-time, continuous X-ray imaging, allowing surgeons to view internal structures and monitor instrument placement during procedures without making large surgical openings. This capability is indispensable in a wide range of MIS applications, including Orthopedic and spine surgeries for fracture fixation and vertebroplasty, Cardiovascular interventions such as stent placements and pacemaker insertions, Urological procedures like ureteroscopy and stone removal, Pain management injections and targeted spinal therapies. By offering dynamic visualization, fluoroscopy reduces procedural risk and helps achieve optimal outcomes making it a standard component in image-guided surgical suites.

The global healthcare landscape is increasingly embracing ambulatory surgical centers (ASCs) and outpatient facilities for performing low-risk, high-efficiency procedures. These centers rely heavily on portable and compact fluoroscopy systems to support fast patient turnover while maintaining clinical accuracy. Minimally invasive surgeries often performed in outpatient settings benefit from fluoroscopy’s speed, mobility, and ease of use. As more procedures shift out of traditional operating rooms into ASCs, demand for cost-effective, high-performance fluoroscopy units is rapidly growing. Today’s patients are more informed and actively involved in their care choices. There is growing preference for less invasive procedures that offer: Shorter recovery times, Lower pain and scarring. Reduced infection risk, Quicker return to daily activities. These preferences are fueling demand for advanced imaging modalities that support such treatments. Fluoroscopy enables surgeons to perform interventions with minimal disruption to surrounding tissues, aligning with patient expectations for faster, safer care especially among the elderly and those with comorbidities.

Download Free Sample Report

Key Market Challenges

High Capital Investment and Maintenance Costs

The most prominent barriers to market growth is the substantial upfront cost associated with acquiring fluoroscopy systems, particularly advanced or hybrid platforms. Installation often requires infrastructure modifications, radiation shielding, and integration with hospital information systems all of which drive up capital expenditure.

Additionally, ongoing maintenance, service contracts, and periodic upgrades further increase the total cost of ownership. This cost burden can be prohibitive for smaller hospitals, rural clinics, and healthcare facilities in emerging markets, where budget allocations are limited and ROI is heavily scrutinized. As a result, procurement decisions are often delayed or redirected toward more affordable alternatives such as portable ultrasound or traditional radiography, particularly in diagnostic scenarios that do not require real-time imaging. This limits market penetration in cost-sensitive regions and among mid-tier providers.

Radiation Safety Concerns and Regulatory Pressure

Despite advancements in dose-reduction technologies, radiation exposure remains a significant concern for both patients and healthcare professionals. Frequent use of fluoroscopy, especially in high-volume interventional procedures, raises the risk of cumulative radiation doses, which can lead to regulatory scrutiny and clinical hesitancy.

Healthcare providers must invest in extensive training, protective gear, and safety protocols to ensure compliance with strict radiation safety standards. In some cases, these safety measures may restrict the operational flexibility of fluoroscopy systems or extend procedure times negatively impacting workflow efficiency and user adoption. Regulatory frameworks around radiation safety and device approval vary significantly across countries, causing delays in product approvals and market access in regions with more stringent compliance requirements.

Key Market Trends

Integration of Hybrid Imaging Systems

The most significant trends driving market expansion is the growing adoption of hybrid radiography-fluoroscopy (RF) systems, which combine static and dynamic imaging capabilities in a single platform. These integrated systems enable healthcare providers to perform both diagnostic and interventional procedures without the need for multiple machines leading to space optimization, cost efficiency, and workflow streamlining.

This dual functionality is especially attractive to hospitals and imaging centers with budget constraints or limited space. It also supports the global shift toward value-based healthcare, where operational efficiency and equipment utilization rates are critical performance metrics. Manufacturers are increasingly designing systems that support multiple clinical applications from orthopedic and cardiovascular procedures to gastrointestinal diagnostics within a single compact footprint, accelerating demand.

Shift Toward Minimally Invasive and Outpatient Procedures

The increasing preference for minimally invasive surgeries (MIS) is a powerful market driver. Fluoroscopy provides real-time, dynamic visualization that is essential for these procedures, helping surgeons navigate with high precision while minimizing tissue damage and recovery time.

As healthcare systems move toward ambulatory surgical centers (ASCs) and outpatient care to reduce costs and hospital stays, fluoroscopy equipment particularly mobile and compact units is becoming indispensable. These systems allow rapid setup and real-time imaging in surgical suites, making them ideal for high-throughput, image-guided interventions.

This trend is also supported by rising volumes of age-related and chronic disease procedures, such as spinal surgeries, vascular interventions, and pain management, all of which require fluoroscopic guidance. As procedural demand grows, so does the need for versatile and efficient imaging solutions.

Segmental Insights

Type Insights

Based on the category of Type, the Fluoroscopy Systems segment emerged as the fastest growing in the market for Fluoroscopy Equipment in 2024. Fluoroscopy systems serve as the backbone of real-time, dynamic imaging, providing continuous X-ray visualization that is critical for a broad spectrum of diagnostic and interventional procedures. These systems are extensively used in cardiology, orthopedics, gastroenterology, and urology, among others, enabling physicians to guide catheters, implants, and contrast agents with precision.

What sets fluoroscopy systems apart from other segments, such as Fixed C-arms or Remote-Controlled Units, is their versatility and adaptability. Modern fluoroscopy platforms often integrate with radiography functions (as seen in hybrid RF systems), offering dual functionality that optimizes space and lowers capital investment for healthcare facilities. This multi-purpose capability makes them a cost-effective and practical choice for hospitals and imaging centers, driving stronger demand.

Ongoing innovation in digital imaging, dose reduction technologies, and workflow automation is enhancing system efficiency, image quality, and patient safety all of which are crucial decision-making factors for procurement teams. Fluoroscopy systems that support real-time navigation, advanced software analytics, and connectivity with hospital information systems are particularly gaining traction in both developed and emerging markets. These factors contribute to the growth of this segment.

Application Insights

Based on the category of Application, the Surgical segment emerged as the dominating in the market for Fluoroscopy Equipment in 2024. Fluoroscopy plays a pivotal role in various surgical disciplines, including orthopedic and trauma surgeries, neurosurgeries, and cardiovascular interventions. In these settings, the ability to visualize anatomical structures dynamically and in real time is crucial for the accurate placement of instruments, implants, and catheters. For instance, in orthopedic surgeries, fluoroscopy is essential for guiding fracture repairs, spinal procedures, and joint replacements with minimal disruption to surrounding tissues.

The increasing demand for image-guided interventions is a major growth catalyst, especially as healthcare systems shift toward day-care surgeries and ambulatory surgical centers (ASCs) that emphasize shorter recovery times and lower patient risk. Fluoroscopy equipment, particularly mobile and hybrid systems, supports this shift by offering flexibility, speed, and precise control during intraoperative imaging. The rising global burden of cardiovascular and neurological disorders has led to an increase in related surgical procedures, many of which depend on fluoroscopic guidance. Advanced surgical fluoroscopy systems now integrate 3D imaging, dose-reduction features, and robotic assistance enhancing surgical outcomes while reducing patient and operator exposure.

Download Free Sample Report

Regional Insights

North America emerged as the largest market in the global Fluoroscopy Equipment market in 2024, holding the largest market share in terms of value. North America holds a dominant position in the global fluoroscopy equipment market, driven by a combination of advanced healthcare infrastructure, high diagnostic imaging volumes, and sustained investments in medical technology. The region particularly the United States has a strong ecosystem of leading medical device manufacturers, research institutions, and hospital networks that are early adopters of cutting-edge imaging technologies, including hybrid fluoroscopy systems and digital radiography-fluoroscopy platforms.

Favorable reimbursement policies and strong regulatory support, such as streamlined FDA 510(k) clearance processes, facilitate quicker market access and accelerate the adoption of next-generation fluoroscopy systems. The rising incidence of chronic diseases, particularly cardiovascular, orthopedic, and gastrointestinal conditions, is contributing to increased procedural volumes requiring real-time imaging guidance. Hospitals and outpatient centers across North America are increasingly relying on fluoroscopy for minimally invasive procedures, catheter placements, and pain management, further driving demand.

Recent Developments

• In March 2025, Canon Medical Systems USA has officially launched the Adora DRFi in the U.S. market following its FDA 510(k) clearance. This advanced hybrid imaging system integrates radiography and fluoroscopy into a unified platform, offering healthcare providers a streamlined, dual-purpose solution designed to enhance workflow efficiency and imaging versatility. Now available for quotation and purchase, the Adora DRFi sets a new benchmark for integrated diagnostic imaging in clinical environments.
• In January 2025, OXOS Medical® has announced that its MC2 Portable X-ray System has received FDA 510(k) clearance and is now commercially available in the United States. Engineered for maximum mobility, the MC2 operates without cords or fixed infrastructure, enabling clinicians to perform diagnostic imaging across a broad range of settings from standard clinical environments to remote or resource-constrained locations. This advancement reflects OXOS Medical’s commitment to redefining accessibility and efficiency in point-of-care imaging.
• In December 2024, Siemens Healthineers has launched the Luminos Q.namix1 platform, a next-generation solution that integrates fluoroscopy and radiography into a single, compact system. This dual-functionality approach is specifically engineered to reduce operational complexity, optimize spatial efficiency, and lower overall system costs for healthcare providers. In response to the productivity challenges caused by cumbersome workflows and fragmented system controls in radiology departments, Siemens Healthineers engaged directly with over 130 fluoroscopy specialists during development. This collaboration enabled the company to design a platform that meaningfully enhances clinical flexibility, streamlines imaging procedures, and improves ergonomic performance targeting the real-world needs of radiology professionals.
• In December 2024, Collingwood General and Marine Hospital (CGMH) has commissioned a state-of-the-art CT scanner, positioning the facility at the forefront of diagnostic imaging capabilities in Canada. As one of the first hospitals in the country to implement this advanced technology, CGMH is strengthening its role as a regional leader in precision diagnostics and accelerating access to high-resolution imaging for patients across Simcoe County.
• In November 2024, Augmedics has received FDA 510(k) clearance for a new registration method within its xvision Spine System®, marking a strategic enhancement to its augmented reality (AR) surgical navigation platform. The newly approved CT-to-fluoroscopy (CT-Fluoro) registration enables surgeons to navigate using preoperative CT data in combination with 2D fluoroscopic images captured from a standard C-arm effectively removing the dependency on 3D intraoperative imaging. This advancement addresses a key obstacle to broader adoption of navigation technologies by simplifying workflow and reducing the need for costly, complex imaging equipment in the operating room.
• In July 2024- the Gibraltar Health Authority introduced advanced diagnostic imaging equipment at St Bernard’s Hospital, marking a significant upgrade in the facility’s clinical capabilities. For the first time, the hospital can now offer real-time imaging services on-site a development that enhances diagnostic accuracy, reduces patient transfer delays, and fills a critical gap in previously unavailable medical services within the facility.
• In July 2024, RUSAN PHARMA PRIVATE LIMITED, an Indian pharmaceutical company focused on addiction treatment and pain management, has announced that the U.S. Food and Drug Administration (USFDA) has granted Good Manufacturing Practice (GMP) approval for its Active Pharmaceutical Ingredient (API) manufacturing facility located in Ankleshwar, Gujarat.   

Key Market Players

• Siemens Healthineers AG
• GE Healthcare
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Medtronic Plc.
• Hologic, Inc.
• Shimadzu Corporation
• Hitachi, Ltd.
• Carestream Health, Inc.
• Allengers Medical Systems Limited

Report Scope:

In this report, the Global Fluoroscopy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Fluoroscopy Equipment Market, By Type:

o   Fixed C-arms

o   Fluoroscopy Systems

o   Remote Controlled Systems

o   Patient-Side Controlled Systems

o   Others

• Fluoroscopy Equipment Market, By Application:

o   Pharmaceuticals

o   Nutraceuticals

o   Herbal Based Industries

o   Others

• Fluoroscopy Equipment Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Imaging Centers

o   Others

• Fluoroscopy Equipment Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fluoroscopy Equipment Market.

Available Customizations:

Global Fluoroscopy Equipment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).